Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Venous Thrombosis 2 Venous Thromboembolism 2 Pulmonary Embolism 2 Neoplasms 2 Multiple Myeloma 2 Urinary Bladder Neoplasms 1 Thrombosis 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1

Interventions

Standard of Care 9 Cystectomy 8 Early Intervention, Educational 7 Cystoscopy 6 Methods 5 Transurethral Resection of Bladder 4 Practice Guidelines as Topic 4 Multiparametric Magnetic Resonance Imaging 4 Exercise 4 Blood Specimen Collection 4 Anesthesia, General 4 Surgical Procedures, Operative 3 Sevoflurane 3 Radiotherapy, Intensity-Modulated 3 Psychiatric Rehabilitation 3 Gemcitabine 3 Diet Therapy 3 Cisplatin 3 Anesthesia, Spinal 3 Watchful Waiting 2 Ultrasonography 2 Therapeutics 2 Surveys and Questionnaires 2 Specimen Handling 2 Saline Solution 2 Robotic Surgical Procedures 2 Radiotherapy 2 Propofol 2 Preoperative Exercise 2 Palliative Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Urinary Bladder Neoplasms × apixaban × Clear all

NCT06243510 2026-01-28

CARE

Abramson Cancer Center at Penn Medicine

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡